These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

175 related items for PubMed ID: 19703225

  • 1. Topical calcineurin inhibitors compromise stratum corneum integrity, epidermal permeability and antimicrobial barrier function.
    Kim M, Jung M, Hong SP, Jeon H, Kim MJ, Cho MY, Lee SH, Man MQ, Elias PM, Choi EH.
    Exp Dermatol; 2010 Jun; 19(6):501-10. PubMed ID: 19703225
    [Abstract] [Full Text] [Related]

  • 2. IL-1α stimulation restores epidermal permeability and antimicrobial barriers compromised by topical tacrolimus.
    Jung YJ, Jung M, Kim M, Hong SP, Choi EH.
    J Invest Dermatol; 2011 Mar; 131(3):698-705. PubMed ID: 21107352
    [Abstract] [Full Text] [Related]

  • 3. Short-term glucocorticoid treatment compromises both permeability barrier homeostasis and stratum corneum integrity: inhibition of epidermal lipid synthesis accounts for functional abnormalities.
    Kao JS, Fluhr JW, Man MQ, Fowler AJ, Hachem JP, Crumrine D, Ahn SK, Brown BE, Elias PM, Feingold KR.
    J Invest Dermatol; 2003 Mar; 120(3):456-64. PubMed ID: 12603860
    [Abstract] [Full Text] [Related]

  • 4. A topical Chinese herbal mixture improves epidermal permeability barrier function in normal murine skin.
    Man M, Hupe M, Mackenzie D, Kim H, Oda Y, Crumrine D, Lee SH, Martin-Ezquerra G, Trullas C, Mauro TM, Feingold KR, Elias PM, Man MQ.
    Exp Dermatol; 2011 Mar; 20(3):285-8. PubMed ID: 21323748
    [Abstract] [Full Text] [Related]

  • 5. Topical apigenin improves epidermal permeability barrier homoeostasis in normal murine skin by divergent mechanisms.
    Hou M, Sun R, Hupe M, Kim PL, Park K, Crumrine D, Lin TK, Santiago JL, Mauro TM, Elias PM, Man MQ.
    Exp Dermatol; 2013 Mar; 22(3):210-5. PubMed ID: 23489424
    [Abstract] [Full Text] [Related]

  • 6. Mechanisms by which psychologic stress alters cutaneous permeability barrier homeostasis and stratum corneum integrity.
    Choi EH, Brown BE, Crumrine D, Chang S, Man MQ, Elias PM, Feingold KR.
    J Invest Dermatol; 2005 Mar; 124(3):587-95. PubMed ID: 15737200
    [Abstract] [Full Text] [Related]

  • 7. Permeability barrier disruption coordinately regulates mRNA levels for key enzymes of cholesterol, fatty acid, and ceramide synthesis in the epidermis.
    Harris IR, Farrell AM, Grunfeld C, Holleran WM, Elias PM, Feingold KR.
    J Invest Dermatol; 1997 Dec; 109(6):783-7. PubMed ID: 9406821
    [Abstract] [Full Text] [Related]

  • 8. Structural basis for the barrier abnormality following inhibition of HMG CoA reductase in murine epidermis.
    Menon GK, Feingold KR, Mao-Qiang M, Schaude M, Elias PM.
    J Invest Dermatol; 1992 Feb; 98(2):209-19. PubMed ID: 1732385
    [Abstract] [Full Text] [Related]

  • 9. Sphingolipids are required for mammalian epidermal barrier function. Inhibition of sphingolipid synthesis delays barrier recovery after acute perturbation.
    Holleran WM, Man MQ, Gao WN, Menon GK, Elias PM, Feingold KR.
    J Clin Invest; 1991 Oct; 88(4):1338-45. PubMed ID: 1918384
    [Abstract] [Full Text] [Related]

  • 10. Optimal ratios of topical stratum corneum lipids improve barrier recovery in chronologically aged skin.
    Zettersten EM, Ghadially R, Feingold KR, Crumrine D, Elias PM.
    J Am Acad Dermatol; 1997 Sep; 37(3 Pt 1):403-8. PubMed ID: 9308554
    [Abstract] [Full Text] [Related]

  • 11. Barrier function regulates epidermal lipid and DNA synthesis.
    Proksch E, Holleran WM, Menon GK, Elias PM, Feingold KR.
    Br J Dermatol; 1993 May; 128(5):473-82. PubMed ID: 8504036
    [Abstract] [Full Text] [Related]

  • 12. Omega-hydroxyceramides are required for corneocyte lipid envelope (CLE) formation and normal epidermal permeability barrier function.
    Behne M, Uchida Y, Seki T, de Montellano PO, Elias PM, Holleran WM.
    J Invest Dermatol; 2000 Jan; 114(1):185-92. PubMed ID: 10620136
    [Abstract] [Full Text] [Related]

  • 13. Altered epidermal lipid layers induced by long-term exposure to suberythemal-dose ultraviolet.
    Bak H, Hong SP, Jeong SK, Choi EH, Lee SE, Lee SH, Ahn SK.
    Int J Dermatol; 2011 Jul; 50(7):832-7. PubMed ID: 21699519
    [Abstract] [Full Text] [Related]

  • 14. Differential suppression of epidermal antimicrobial protein expression in atopic dermatitis and in EFAD mice by pimecrolimus compared to corticosteroids.
    Jensen JM, Ahrens K, Meingassner J, Scherer A, Bräutigam M, Stütz A, Schwarz T, Fölster-Holst R, Harder J, Gläser R, Proksch E.
    Exp Dermatol; 2011 Oct; 20(10):783-8. PubMed ID: 21707760
    [Abstract] [Full Text] [Related]

  • 15. Co-regulation and interdependence of the mammalian epidermal permeability and antimicrobial barriers.
    Aberg KM, Man MQ, Gallo RL, Ganz T, Crumrine D, Brown BE, Choi EH, Kim DK, Schröder JM, Feingold KR, Elias PM.
    J Invest Dermatol; 2008 Apr; 128(4):917-25. PubMed ID: 17943185
    [Abstract] [Full Text] [Related]

  • 16. Pseudoceramide stimulates peroxisome proliferator-activated receptor-α expression in a murine model of atopic dermatitis: molecular basis underlying the anti-inflammatory effect and the preventive effect against steroid-induced barrier impairment.
    Lee SE, Jung MK, Oh SJ, Jeong SK, Lee SH.
    Arch Dermatol Res; 2015 Nov; 307(9):781-92. PubMed ID: 26121942
    [Abstract] [Full Text] [Related]

  • 17. Topical mevalonic acid stimulates de novo cholesterol synthesis and epidermal permeability barrier homeostasis in aged mice.
    Haratake A, Ikenaga K, Katoh N, Uchiwa H, Hirano S, Yasuno H.
    J Invest Dermatol; 2000 Feb; 114(2):247-52. PubMed ID: 10651982
    [Abstract] [Full Text] [Related]

  • 18. Topical hesperidin prevents glucocorticoid-induced abnormalities in epidermal barrier function in murine skin.
    Man G, Mauro TM, Kim PL, Hupe M, Zhai Y, Sun R, Crumrine D, Cheung C, Nuno-Gonzalez A, Elias PM, Man MQ.
    Exp Dermatol; 2014 Sep; 23(9):645-51. PubMed ID: 24980072
    [Abstract] [Full Text] [Related]

  • 19. Expression of antimicrobial peptides such as LL-37 and hBD-2 in nonlesional skin of atopic individuals.
    Goo J, Ji JH, Jeon H, Kim MJ, Jeon SY, Cho MY, Lee SH, Choi EH.
    Pediatr Dermatol; 2010 Sep; 27(4):341-8. PubMed ID: 20653851
    [Abstract] [Full Text] [Related]

  • 20. Restoring tacrolimus-induced impaired barrier function.
    Aber C, Kirsner RS.
    J Invest Dermatol; 2011 Mar; 131(3):554. PubMed ID: 21307949
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.